New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cytocom, Inc.
CBLI
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

226M

Biotechnology

3.17USD

Shape-0.25 ( -7.31%)
moonAfter-hours NaN$arrow-right-up0.00 (0.00%)
Market Closed (as of Sep 01, 04:00 EDT)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-26%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

9%

Quote Panel

Shape
Updated February 18, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap

    226.39M


  • Shares Outstanding

    71.42M


  • Share in Float

    47.55M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    3.17


  • Average Volume

    156953


  • Beta

    0.683695


  • Range

    3.11-3.5


  • Industry

    Biotechnology


  • Website

    http://www.cytocom.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

860.98x

P/S Ratio

19.52x

P/B Ratio

1.3

Debt/Equity

-912.2%

Net Margin

$0.0

EPS

How CBLI compares to sector?

P/E Ratio

Relative Strength

Shape

CBLI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.19

arrow
arrow

N/A

-0.08
vs -0.11

Q2.19

arrow
arrow

N/A

-0.05
vs -0.08

Q3.19

arrow
arrow

N/A

-0.04
vs -0.10

Q4.19

arrow
arrow

N/A

-0.06
vs -0.04

Q1.20

arrow
arrow

N/A

-0.05
vs -0.08

Q2.20

arrow
arrow

N/A

-0.03
vs -0.05

Q3.20

arrow
arrow

N/A

-0.06
vs -0.04

Q4.20

arrow
arrow

N/A

-0.05
vs -0.06

Q1.21

arrow
arrow

N/A

-0.04
vs -0.05

Q2.21

arrow
arrow

N/A

-0.04
vs -0.03

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.19

arrow
arrow

-13%

197.9K  vs 227.6K

Q2.19

arrow
arrow

-29%

277K  vs 391.6K

Q3.19

arrow
arrow

-5%

269.6K  vs 283.3K

Q4.19

arrow
arrow

+57%

368.9K  vs 235.7K

Q1.20

arrow
arrow

-21%

156K  vs 197.9K

Q2.20

arrow
arrow

-77%

63.3K  vs 277K

Q3.20

arrow
arrow

-84%

43.6K  vs 269.6K

Q4.20

arrow
arrow

-100%

2.62942e-7  vs 368.9K

Q1.21

arrow
arrow

-100%

NA  vs 156K

Q2.21

arrow
arrow

-100%

NA  vs 63.3K

Return on EquityShape

status-upQoQ

Q3.19

arrow
arrow

-27%

-0.27
vs -0.29

Q4.19

arrow
arrow

-72%

-0.72
vs -0.27

Q1.20

arrow
arrow

-76%

-0.76
vs -0.72

Q2.20

arrow
arrow

-11%

-0.11
vs -0.76

Q3.20

arrow
arrow

-27%

-0.27
vs -0.11

Q4.20

arrow
arrow

-35%

-0.35
vs -0.27

Q1.21

arrow
arrow

-6%

-0.06
vs -0.35

Q2.21

arrow
arrow

-5%

-0.05
vs -0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.19

arrow
arrow

11

11
vs 7

57%

Q4.19

arrow
arrow

9

9
vs 11

-18%

Q1.20

arrow
arrow

11

11
vs 9

22%

Q2.20

arrow
arrow

12

12
vs 11

9%

Q3.20

arrow
arrow

14

14
vs 12

17%

Q4.20

arrow
arrow

17

17
vs 14

21%

Q1.21

arrow
arrow

19

19
vs 17

12%

Q2.21

arrow
arrow

19

19
vs 19

NA

Earnings Growth

Latest News